Cargando…
N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common respiratory disorder for which new diagnostic and therapeutic approaches are required. Hallmarks of COPD are matrix destruction and neutrophilic airway inflammation in the lung. We have previously described two tri-peptides, N-α-PG...
Autores principales: | O'Reilly, Philip, Jackson, Patricia L, Noerager, Brett, Parker, Suzanne, Dransfield, Mark, Gaggar, Amit, Blalock, J Edwin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693492/ https://www.ncbi.nlm.nih.gov/pubmed/19450278 http://dx.doi.org/10.1186/1465-9921-10-38 |
Ejemplares similares
-
Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013) -
The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeability
por: Hahn, Cornelia S., et al.
Publicado: (2015) -
Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation
por: Gaggar, Amit, et al.
Publicado: (2010) -
PGP: Pretty Good Privacy
por: Garfinkel, Simson
Publicado: (1995) -
PGP & GPG: email for the practical paranoid
por: Lucas, Michael
Publicado: (2006)